The benefit of Vaccination against severe COVID 19 for patients who are on dialysis
In an analysis of patients with kidney failure receiving dialysis who had become infected with SARS- CoV-2, those who were vaccinated had a lower risk of experiencing severe COVID-19. The findings, which are published in CJASN, reiterate the benefits of COVID-19 vaccination in this patient population.Various studies have shown that individuals on hemodialysis have impaired immune responses...
In an analysis of patients with kidney failure receiving dialysis who had become infected with SARS- CoV-2, those who were vaccinated had a lower risk of experiencing severe COVID-19. The findings, which are published in CJASN, reiterate the benefits of COVID-19 vaccination in this patient population.
Various studies have shown that individuals on hemodialysis have impaired immune responses to COVID-19 vaccines, but few studies have described the efficacy of COVID-19 vaccination in such patients.
To investigate, Debasish Banerjee, MD, FRCP (St. George's University Hospitals NHS Foundation Trust, London) and his colleagues conducted a multi-center observational study of patients who were receiving hemodialysis in London and who were being regularly tested for COVID-19 during the period of vaccine roll-out with Pfizer-BioNtech's BNT162b2 and AstraZeneca's AZD1222.
SARS-CoV-2 infection was identified in 1,323 patients of different ethnicities (Asian/other 30%, Black 38%, and White 32%) including 1,047 (79%) unvaccinated, 86 (7%) post–first-dose, and 190 (14%) post–second-dose vaccination.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd